Advertisement

Home / India / Johnson & Johnson seeks India nod for jab trials for children

Johnson & Johnson seeks India nod for jab trials for children

Pharma major wants to perform study on kids aged between 12 to 17
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in a statement
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in a statement
File picture

Reuters   |   New Delhi   |   Published 20.08.21, 02:26 PM

Johnson & Johnson (JNJ.N) has sought approval from Indian drug regulators to conduct a study of its COVID-19 vaccine among 12- to 17-year-olds, the company said on Friday.

Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement.

The U.S. pharma giant had received emergency use approval for its single-dose vaccine in India earlier this month, making it the fifth authorised vaccine in the country.

While J&J has a supply agreement with Indian vaccine maker Biological E Ltd to bring its shot to the country, the company had said that it was too early to give a delivery timeline.



Advertisement
Advertisement
Advertisement
 
 
 
Copyright © 2020 The Telegraph. All rights reserved.